Skip to main content
News

Rockville Expansion | Merck KGaA, Darmstadt, Germany

By November 21, 2022No Comments
Scientist working in the hospital with microscope 2022 03 07 22 34 56 utc

Scientist working in the hospital with microscope 2022 03 07 22 34 56 utcMerck KGaA, Darmstadt, Germany, a leading science and technology company, invests more than € 290 million in its biosafety testing capacity at Rockville, Maryland, USA. This will significantly increase the company’s ability to conduct biosafety testing and analytical development services. Biosafety testing and analytical development are critical and fundamental requirements of the drug development and commercialization process to ensure the safety of medicines. Global demand for these services is growing at a double-digit rate.

 

{iframe}https://www.emdgroup.com/en/news/rockville-expansion-17-11-2022.html{/iframe}

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.